Abstract:The aim of the present study was to examine the impact of childhood trauma on HPA axis activity both in depression patients and healthy controls in order to determine the role of HPA axis abnormalities in depression and to find the differences in HPA axis functioning that may lead certain individuals more susceptible to the depressogenic effects of childhood trauma. Eighty subjects aged 18-45 years were recruited into four study groups (n = 18, depression patients with childhood trauma exposures, CTE/ MDD; n = 17, depression patients without childhood adversity, non-CTE/MDD; n = 23, healthy persons with childhood trauma, CTE/non-MDD; and n = 22, healthy persons without childhood adversity, non-CTE/non-MDD). Each participant collected salivary samples in the morning at four time points: immediately upon awakening, 30, 45, and 60 min after awakening for the assessment of CAR and underwent a 1 mg-dexamethasone suppression test (DST). Regardless of depression, subjects with CTE exhibited an enhanced CAR and the CAR areas under the curve to ground (AUCg) were associated with their childhood trauma questionnaire (CTQ) physical neglect scores and CTQ total scores. In addition, the CTE/MDD group also showed a highest post-DST cortisol concentration and a decreased glucocorticoid feedback inhibition among four groups of subjects. The present findings suggested that childhood trauma was associated with hyperactivity of HPA axis as measured with CAR, potentially reflecting the vulnerability for developing depression after early life stress exposures. Moreover, dysfunction of the GR-mediated negative feedback control might contribute to the development of depression after CTE. (C) 2016 Elsevier Ltd. All rights reserved.

Relationship between the dexamethasone suppression test and the L-tryptophan/competing amino acids ratio in depression.

The Diagnostic Performance of the L-tryptophan/competing Amino Acids Ratio in Major Depression.

The Relationships Between The Cortisol Responses To Dexamethasone And To L-5-Htp, And The Availability Of L-Tryptophan In Depressed Females

Effects of dexamethasone on the availability of L-tryptophan and on the insulin and FFA concentrations in unipolar depressed patients.

Suppressant effects of dexamethasone on the availability of plasma L-tryptophan and tyrosine in healthy controls and in depressed patients.

The influences of dexamethasone levels on the predictive value of the DST for unipolar major depression and relationships between post-dexamethasone cortisol and ACTH levels

The effects of glucocorticoids on the availability of L-tryptophan and tyrosine in the plasma of depressed patients

L-5-Hydroxytryptophan Stimulated Cortisol Escape from Dexamethasone Suppression in Melancholic Patients

The Dexamethasone Suppression Test, the Hamilton Depression Rating Scale and the DSM-III Depression Categories

In Search of the HPA Axis Activity in Unipolar Depression Patients with Childhood Trauma: Combined Cortisol Awakening Response and Dexamethasone Suppression Test

Serum postdexamethasone prolactin measures in depressive patients and control subjects

Symptom Profiles of Biological Markers in Depression: a Multivariate Study.

The Decreased Availability of L-tryptophan in Depressed Females: Clinical and Biological Correlates

Results of the 8 A.m. Dexamethasone Suppression Test Constitute a Suitable Tool for Confirming the Diagnosis of Melancholia

A revised interpretation of postdexamethasone ACTH and cortisol findings in unipolar depressed females.

The Cortisol Suppression Index and the Dexamethasone Suppression Test in Major Depression.

HPA-axis Hormones and Prolactin Responses to Dextro-Fenfluramine in Depressed Patients and Healthy Controls.

Influences on cortisol and noradrenergic turnover of healthy controls and depressed patients during L-tryptophan loading

Positive Relationship Between the Catecholaminergic Turnover and the DST Results in Depression

Results of the 8 a.m. dexamethasone suppression test constitute a suitable tool for confirming the diagnosis of melancholia. A test unaffected by the variations in the bioavailability of dexamethasone.

Disturbances in dexamethasone suppression test and lower availability of Ł-tryptophan and tyrosine in early puerperium and in women under contraceptive therapy